Quiz: Pharmacovigilance: Signal Detection and Case Processing With AI

Signal detection in pharmacovigilance aims to identify potential safety issues that were not evident during clinical trials or initial product approval.

Traditional signal detection methods depend largely on manual review by clinical specialists examining individual case reports.

Artificial intelligence systems can analyse data patterns across patient demographics, drug interactions, and temporal relationships between drug administration and adverse events.

AI systems for case processing can automatically categorise adverse event reports based on predefined categories using natural language processing.

Organisations must ensure data integrity when implementing AI systems because poor quality input data affects AI performance.